202 related articles for article (PubMed ID: 34492730)
1. Myeloid malignancies with translocation t(4;12)(q11-13;p13): molecular landscape, clonal hierarchy and clinical outcomes.
Parinet V; Chapiro E; Bidet A; Gaillard B; Maarek O; Simon L; Lefebvre C; Defasque S; Mozziconacci MJ; Quinquenel A; Decamp M; Lifermann F; Ali-Ammar N; Maillon A; Baron M; Martin M; Struski S; Penther D; Micol JB; Auger N; Bilhou-Nabera C; Martignoles JA; Tondeur S; Nguyen-Khac F; Hirsch P; Roos-Weil D;
J Cell Mol Med; 2021 Oct; 25(20):9557-9566. PubMed ID: 34492730
[TBL] [Abstract][Full Text] [Related]
2. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.
Haferlach C; Bacher U; Schnittger S; Alpermann T; Zenger M; Kern W; Haferlach T
Genes Chromosomes Cancer; 2012 Apr; 51(4):328-37. PubMed ID: 22162288
[TBL] [Abstract][Full Text] [Related]
3. Myeloid neoplasms associated with t(3;12)(q26.2;p13) are clinically aggressive, show myelodysplasia, and frequently harbor chromosome 7 abnormalities.
Ronaghy A; Hu S; Tang Z; Wang W; Tang G; Loghavi S; Li S; Thakral B; Medeiros LJ; Muzzafar T
Mod Pathol; 2021 Feb; 34(2):300-313. PubMed ID: 33110238
[TBL] [Abstract][Full Text] [Related]
4. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
5. Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): A unique molecular-cytogenetic subgroup.
Hong M; Hao S; Patel KP; Kantarjian HM; Garcia-Manero G; Yin CC; Medeiros LJ; Lin P; Lu X
Cancer Genet; 2016 May; 209(5):205-14. PubMed ID: 27134073
[TBL] [Abstract][Full Text] [Related]
6. Utilizing next-generation sequencing to characterize a case of acute myeloid leukemia with t(4;12)(q12;p13) in the absence of ETV6/CHIC2 and ETV6/PDGFRA gene fusions.
Koleilat A; McGarrah PW; Olteanu H; Van Dyke DL; Smadbeck JB; Johnson SH; Vasmatzis G; Hoppman NL; Xu X; Ketterling RP; Greipp PT; Baughn LB; Patnaik MS; Peterson JF
Cancer Genet; 2022 Jan; 260-261():1-5. PubMed ID: 34781094
[TBL] [Abstract][Full Text] [Related]
7. Acute Myeloid Leukemia With t(v;5q33) Is Associated With Poor Overall Survival and Often Lacks Myelodysplastic Features.
Yabe M; Tang G; Garcia-Manero G; Loghavi S; Lu X; Miranda RN; Medeiros LJ; Kantarjian HM; Bueso-Ramos CE; Khoury JD
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S85-90. PubMed ID: 26297286
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
[TBL] [Abstract][Full Text] [Related]
9. Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens.
Reddi DM; Lu CM; Fedoriw G; Liu YC; Wang FF; Ely S; Boswell EL; Louissaint A; Arcasoy MO; Goodman BK; Wang E
Am J Clin Pathol; 2012 Dec; 138(6):855-66. PubMed ID: 23161720
[TBL] [Abstract][Full Text] [Related]
10. Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as "AML not otherwise specified" (AML-NOS) or "AML with myelodysplasia-related changes" (AML-MRC).
Miesner M; Haferlach C; Bacher U; Weiss T; Macijewski K; Kohlmann A; Klein HU; Dugas M; Kern W; Schnittger S; Haferlach T
Blood; 2010 Oct; 116(15):2742-51. PubMed ID: 20581309
[TBL] [Abstract][Full Text] [Related]
11. The New Clinicopathologic and Molecular Findings in Myeloid Neoplasms With inv(3)(q21q26)/t(3;3)(q21;q26.2).
Wang HY; Rashidi HH
Arch Pathol Lab Med; 2016 Dec; 140(12):1404-1410. PubMed ID: 27628325
[TBL] [Abstract][Full Text] [Related]
12. ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype.
Prats-Martín C; Burillo-Sanz S; Morales-Camacho RM; Pérez-López O; Suito M; Vargas MT; Caballero-Velázquez T; Carrillo-Cruz E; González J; Bernal R; Pérez-Simón JA
Cancer Med; 2020 Jun; 9(11):3637-3646. PubMed ID: 32216059
[TBL] [Abstract][Full Text] [Related]
13. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases.
Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S
Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804
[TBL] [Abstract][Full Text] [Related]
14. The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms.
Gurney M; Chekkaf I; Baranwal A; Basmaci R; Katamesh B; Greipp P; Foran JM; Badar T; Mangaonkar AA; Begna KH; Gangat N; Patnaik MM; Litzow MR; Shah MV; Viswanatha DS; He R; Alkhateeb HB; Al-Kali A
Br J Haematol; 2023 Jul; 202(2):279-283. PubMed ID: 37144345
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of acute myeloid leukemia with myelodysplasia-related changes: A retrospective analysis in a cohort of Chinese patients.
Xu XQ; Wang JM; Gao L; Qiu HY; Chen L; Jia L; Hu XX; Yang JM; Ni X; Chen J; Lü SQ; Zhang WP; Song XM
Am J Hematol; 2014 Sep; 89(9):874-81. PubMed ID: 24861848
[TBL] [Abstract][Full Text] [Related]
16. t(5;12)(q31;p13)/ETV6::ACSL6 and t(6;9)(p23;q34)/DEK::NUP214 concurrence in acute myeloid leukemia: an unusual association of two rare abnormalities.
Baldazzi C; Luatti S; Marzocchi G; Grassi A; Cavo M; Testoni N
Cancer Genet; 2022 Apr; 262-263():35-39. PubMed ID: 34979355
[TBL] [Abstract][Full Text] [Related]
17. Pediatric acute myeloid leukemia with t(7;21)(p22;q22).
Paulraj P; Diamond S; Razzaqi F; Ozeran JD; Longhurst M; Andersen EF; Toydemir RM; Hong B
Genes Chromosomes Cancer; 2019 Aug; 58(8):551-557. PubMed ID: 30706625
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
19. Description of an Institutional Cohort of Myeloid Neoplasms Carrying ETV6-Locus Deletions or ETV6 Rearrangements.
Papadopoulou V; Schoumans J; Scarpelli I; Blum S
Acta Haematol; 2023; 146(5):401-407. PubMed ID: 36848872
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization analysis of t(3; 12)(q26; p13): a recurring chromosomal abnormality involving the TEL gene (ETV6) in myelodysplastic syndromes.
Raynaud SD; Baens M; Grosgeorge J; Rodgers K; Reid CD; Dainton M; Dyer M; Fuzibet JG; Gratecos N; Taillan B; Ayraud N; Marynen P
Blood; 1996 Jul; 88(2):682-9. PubMed ID: 8695816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
